Letter to the Editor

Multidrug-Resistant TB as A Major Concern for Tuberculosis Control Programs

World Health Organization (2006). The Tuberculosis Coalition for Technical Assistance. International Standards of Care. Available from:


Mukherjee JS, Rich ML, Socci AR, Joseph JK, Virú FA, Shin SS, et al. (2004). Programmes and principles in treatment of multidrug-resistant tuberculosis. The Lancet, 363 (9407):474-81.

Toungoussova O, Mariandyshev A, Bjune G, Caugant D, Sandven P (2005). Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs. Europ J Clin Microbiol Infect Dis, 24(3):202-6.

World Health Organization. Multidrug-resistant tuberculosis (MDR-TB) (2013). Available from: http://www.who.int/tb/publica-tions/MDRFactSheet2012. pdf

World Health Organization (2014). “Global Tuberculosis Report 2014″, WHO, Geneva, Available from:


Jaramillo E (2008). Guidelines for the programmatic management of drug-resistant tuberculosis. World Health Organization.pp.:8-13

IssueVol 45 No 1 (2016) QRcode
SectionLetter to the Editor

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
KHAZAEI S, SALEHINIYA H, SOLTANI S, MOHAM­MADIAN-HAFSHEJANIA. Multidrug-Resistant TB as A Major Concern for Tuberculosis Control Programs. Iran J Public Health. 2016;45(1):114-115.